283 related articles for article (PubMed ID: 17934259)
1. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid.
Escribano I; Rodríguez JC; Llorca B; García-Pachon E; Ruiz M; Royo G
Chemotherapy; 2007; 53(6):397-401. PubMed ID: 17934259
[TBL] [Abstract][Full Text] [Related]
2. Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis.
Rodríguez JC; Cebrián L; López M; Ruiz M; Jiménez I; Royo G
J Antimicrob Chemother; 2004 Mar; 53(3):441-4. PubMed ID: 14963069
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis.
Rodríguez JC; Ruiz M; López M; Royo G
Int J Antimicrob Agents; 2002 Dec; 20(6):464-7. PubMed ID: 12458143
[TBL] [Abstract][Full Text] [Related]
5. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
[TBL] [Abstract][Full Text] [Related]
6. Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis.
García-Tapia A; Rodríguez JC; Ruiz M; Royo G
Chemotherapy; 2004 Nov; 50(5):211-3. PubMed ID: 15523179
[TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms.
Cebrián L; Rodríguez JC; Escribano I; Royo G
Chemotherapy; 2005 Mar; 51(1):40-3. PubMed ID: 15767744
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of various antibiotics against Mycobacterium avium-intracellulare, measured by their mutant prevention concentration.
Rodríguez JC; Cebrián L; López M; Ruiz M; Royo G
Int J Antimicrob Agents; 2005 Mar; 25(3):221-5. PubMed ID: 15737516
[TBL] [Abstract][Full Text] [Related]
10. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
11. gyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China.
Long Q; Li W; Du Q; Fu Y; Liang Q; Huang H; Xie J
Int J Antimicrob Agents; 2012 Jun; 39(6):486-9. PubMed ID: 22526012
[TBL] [Abstract][Full Text] [Related]
12. High incidence of fluoroquinolone resistance and effect of efflux pump inhibitors on moxifloxacin resistance among Mycobacterium tuberculosis isolates causing urinary tract infection in Taiwan.
Chien JY; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2017 Sep; 50(3):491-495. PubMed ID: 28668684
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the Mycobacterium tuberculosis reserpine-sensitive efflux pump augments intracellular concentrations of ciprofloxacin and enhances susceptibility of some clinical isolates.
Huang TS; Kunin CM; Wang HM; Yan BS; Huang SP; Chen YS; Lee SS; Syu WJ
J Formos Med Assoc; 2013 Dec; 112(12):789-94. PubMed ID: 24331109
[TBL] [Abstract][Full Text] [Related]
14. The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp.
Escribano I; Rodríguez JC; Cebrian L; Royo G
Int J Antimicrob Agents; 2004 Nov; 24(5):428-32. PubMed ID: 15519472
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002.
Noguchi N; Okihara T; Namiki Y; Kumaki Y; Yamanaka Y; Koyama M; Wakasugi K; Sasatsu M
Int J Antimicrob Agents; 2005 May; 25(5):374-9. PubMed ID: 15848290
[TBL] [Abstract][Full Text] [Related]
16. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
Umubyeyi AN; Rigouts L; Shamputa IC; Fissette K; Elkrim Y; de Rijk PW; Struelens MJ; Portaels F
J Antimicrob Chemother; 2007 May; 59(5):1031-3. PubMed ID: 17329272
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
Von Groll A; Martin A; Jureen P; Hoffner S; Vandamme P; Portaels F; Palomino JC; da Silva PA
Antimicrob Agents Chemother; 2009 Oct; 53(10):4498-500. PubMed ID: 19687244
[TBL] [Abstract][Full Text] [Related]
18. Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility.
Cattoir V; Nectoux J; Lascols C; Deforges L; Delchier JC; Megraud F; Soussy CJ; Cambau E
Int J Antimicrob Agents; 2007 Apr; 29(4):389-96. PubMed ID: 17303392
[TBL] [Abstract][Full Text] [Related]
19. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
Zheng J; Cui S; Meng J
J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
[TBL] [Abstract][Full Text] [Related]
20. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates.
Cheng AF; Yew WW; Chan EW; Chin ML; Hui MM; Chan RC
Antimicrob Agents Chemother; 2004 Feb; 48(2):596-601. PubMed ID: 14742214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
